Hey, melissa, these results were so much better, and if all went really well melissa, we have 90 of efficacy with this trial and this Covid Vaccine from pfizer. This is a 44,000participant trial. The way they measure efficacy is how many cases of covid they see in the trial they want to see more cases in the placebo arm than the vaccine arm, to show that the vaccine is protective thats what they saw to the opportunity of 90 efficacy. They said they saw no serious safety concerns, and they will proceed to the end of the twomonth safety followup window before they would seek emergency use authorization. That will happen next week after that we could see them proceeding for regulatory clearance. There are still questions remains. This was just topline data, and it looks to be safe, but theres still questions how does it prevent severe disease does it prevent infection completely or just manifestation of the disease with symptoms other questions are how long did the protection last . Weve